Cell Surface Tagging and a Suicide Mechanism in a Single Chimeric Human Protein
- 10 November 1999
- journal article
- research article
- Published by Mary Ann Liebert Inc in Human Gene Therapy
- Vol. 10 (16) , 2651-2655
- https://doi.org/10.1089/10430349950016681
Abstract
Many therapeutic uses of gene-modified cells could benefit from inclusion of a surface marker for immunoselecting transduced cells. Another desired feature is a failsafe mechanism to ablate engineered cells if required. We describe here a system that combines a cell surface tag and an inducible apoptosis mechanism in a single protein. Spencer et al. (Curr. Biol. 1996;6:839-847) described an inducible cell suicide gene containing a myristoylation sequence, the human protein FKBP12, and the intracellular domain of Fas. Cells expressing this protein apoptose on treatment with a cell-permeable chemical dimerizing agent that binds two FKBP domains and cross-links the chimeric Fas proteins. We modified this system by anchoring a Fas-FKBP construct to the membrane with the extracellular and transmembrane domains of the low-affinity nerve growth factor receptor (LNGFR), thereby uniting cell surface tagging with the inducible apoptosis mechanism. Cells retrovirally transduced with this construct apoptosed on exposure to a chemical dimerizer, AP1903 (Clackson et al., Proc. Natl. Acad. Sci. U.S.A. 1998;95:10437-10442). The LNGFR-tagged construct showed an unpredicted clear advantage over the myristoylation-anchored construct in its efficiency of signaling in HT1080 cells. This linked marker and failsafe mechanism may have particularly attractive safety properties for gene therapy.Keywords
This publication has 15 references indexed in Scilit:
- “Suicide” gene for the control of graft-versus-host diseaseCurrent Opinion in Hematology, 1998
- Herpes Simplex Virus Thymidine Kinase Gene Transfer for Controlled Graft-versus-Host Disease and Graft-versus-Leukemia: Clinical Follow-up and Improved New VectorsHuman Gene Therapy, 1998
- Redesigning an FKBP–ligand interface to generate chemical dimerizers with novel specificityProceedings of the National Academy of Sciences, 1998
- Death Receptors: Signaling and ModulationScience, 1998
- HSV-TK Gene Transfer into Donor Lymphocytes for Control of Allogeneic Graft-Versus-LeukemiaScience, 1997
- Cell–surface markers for assessing gene transfer into human hematopoietic cellsNature Medicine, 1996
- Functional analysis of Fas signaling in vivo using synthetic inducers of dimerizationCurrent Biology, 1996
- T–cell mediated rejection of gene–modified HIV–specific cytotoxic T lymphocytes in HIV–infected patientsNature Medicine, 1996
- BCR first exon sequences specifically activate the BCR/ABL tyrosine kinase oncogene of Philadelphia chromosome-positive human leukemias.Molecular and Cellular Biology, 1991
- Characterization of nerve growth factor receptor in neural crest tumors using monoclonal antibodies.Proceedings of the National Academy of Sciences, 1984